Voyageur Completes Human Testing of Barium Contrast Products and Prepares for Canadian Market Launch

Stock Information for Voyageur Pharmaceuticals Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Voyageur Pharmaceuticals Ltd.

Voyageur Launches Market Introduction of Barium Contrast Product Line Following Successful Clinical Study Results
Voyageur Pharmaceuticals Grants Deferred Share Units
Voyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product Line
Voyageur Clarifies Terms of Previously Announced Agreement
Voyageur Pharmaceuticals Grants Deferred Share Units
Voyageur Advances MRI Drug Development Using Next Generation Endohedral Fullerenes
Voyageur Receives $600K Grant from Alberta Innovates for Product Development
Voyageur Secures $687k of Additional Capital from Warrant Exercises

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.